Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

[Summary of the multidisciplinary guideline on cardiovascular risk management (revision 2011)].

Wiersma T, Smulders YM, Stehouwer CD, Konings KT, Lanphen J.

Ned Tijdschr Geneeskd. 2012;156(36):A5104. Review. Dutch.

PMID:
22951134
2.

Incorporation of economic evidence in the Dutch guideline 'cardiovascular risk management'.

Tan SS, Rutten FF, Hakkaart-van Roijen L.

J Eval Clin Pract. 2011 Dec;17(6):1094-101. doi: 10.1111/j.1365-2753.2010.01481.x. Epub 2010 Oct 12.

PMID:
21040249
3.

ESH-ESC guidelines for the management of hypertension.

Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.

Herz. 2006 Jun;31(4):331-8.

PMID:
16810473
4.

The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.

Hemmelgarn BR, Zarnke KB, Campbell NR, Feldman RD, McKay DW, McAlister FA, Khan N, Schiffrin EL, Myers MG, Bolli P, Honos G, Lebel M, Levine M, Padwal R; Canadian Hypertension Education Program, Evidence-Based Recommendations Task Force.

Can J Cardiol. 2004 Jan;20(1):31-40.

PMID:
14968141
5.

[Dutch guideline for cardiovascular risk management: a consensus model].

Kroon AA.

Ned Tijdschr Geneeskd. 2012;156(36):A5196. Dutch.

PMID:
22951135
6.

Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.

Wens J, Gerard R, Vandenberghe H.

Prim Care Diabetes. 2011 Apr;5(1):19-24. doi: 10.1016/j.pcd.2010.09.006. Epub 2010 Oct 27.

PMID:
21030327
7.

[The guideline 'Cardiovascular risk management' is too simplified for elderly care].

de Ruijter W, Gussekloo J.

Ned Tijdschr Geneeskd. 2012;156(36):A5197. Dutch.

PMID:
22951136
8.
9.

EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.

Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z, Keil U; EUROASPIRE Study Group.

Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):530-40. doi: 10.1097/HJR.0b013e3283383f30.

PMID:
20577089
10.

What have we learned from the current trials?

Abbott KC, Bakris GL.

Med Clin North Am. 2004 Jan;88(1):189-207. Review.

PMID:
14871059
11.
12.

[Pharmacological prevention of cardiovascular diseases in general practice].

Meland E, Ellekjaer H, Gjelsvik B, Kimsås A, Holmen J, Hetlevik I.

Tidsskr Nor Laegeforen. 2000 Sep 20;120(22):2643-7. Norwegian.

13.
14.

[Prevention of cardiovascular disease in type 2 diabetic patients].

Yokota C.

Nihon Rinsho. 2003 Jul;61(7):1161-6. Review. Japanese.

PMID:
12877078
15.

Management of hypertension in diabetic patients: outstanding issues.

Camafort-Babkowski M, Barrios V, Coca A.

Expert Rev Cardiovasc Ther. 2011 Jun;9(6):721-8. doi: 10.1586/erc.11.77. Review.

PMID:
21714603
16.

The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.

Kok L, Engelfriet P, Jacobs-van der Bruggen MA, Hoogenveen RT, Boshuizen HC, Verschuren MW.

Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):371-6. doi: 10.1097/HJR.0b013e328329497a.

PMID:
19305351
17.

Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.

Basile J, Houston M, Ferrario CM.

J Cardiometab Syndr. 2006 Fall;1(5):358-61. No abstract available.

18.

Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".

Paraskevas KI.

J Vasc Surg. 2008 Sep;48(3):776-7; author reply 777. doi: 10.1016/j.jvs.2008.04.074. No abstract available.

19.
20.

The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C; Canadian Hypertension Education Program.

Can J Cardiol. 2004 Jan;20(1):41-54.

PMID:
14968142

Supplemental Content

Support Center